Overall change in health‐related quality of life · women with aromatase inhibitor‐induced musculoskeletal symptoms (AIMSS)
1 finding from 1 review
Quality of life/life satisfaction ‐ not measured · people with both severe mental illness and substance misuse
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life/life satisfaction ‐ not measured · people with both severe mental illness and substance misuse
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life/life satisfaction ‐ not measured · people with both severe mental illness and substance misuse
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life/life satisfaction ‐ not measured · people with both severe mental illness and substance misuse
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Health‐related quality of life: up to 3 months ( · participants with alcoholic hepatitis at high risk of mortality and morbidity
The intervention showed no clear difference in health‐related quality of life: up to 3 months ( (low certainty).
1 finding from 1 review
No problems in quality of life domains at one year · people with neovascular age‐related macular degeneration
Summary of findings: bevacizumab showed no clear difference in no problems in quality of life domains at 1 year compared with ranibizumab (moderate certainty).
1 finding from 1 review
Quality of life at time point closest to 90 days · participants with internal medicine diseases and conditions
1 finding from 1 review
no estimate extracted
1029 participants
Very low
Quality of life: improved to an important degree · people with psychosis
3 findings from 1 review
no estimate extracted
0 studies · 0 participants
GRADE not reported
no estimate extracted
0 studies · 0 participants
GRADE not reported
no estimate extracted
0 studies · 0 participants
GRADE not reported
Intervention not reported
Asthma‐related quality of life (AQLQ)i 9.6‐month · people with asthma
1 finding from 1 review
Intervention not reported
Overall quality of life change score ‐ 6 months' · Cancer survivors who have completed active cancer treatment
1 finding from 1 review
Quality of life (self‐rating by the participants; · people with dementia
1 finding from 1 review
Quality of life (any measure): range 180 d to 1 y · adults admitted to the ICU
1 finding from 1 review
Change in patient‐reported quality of life scores · people with dry eye
The review found no eligible studies for this question.
1 finding from 1 review
Change in patient‐reported quality of life scores · people with dry eye
The review found no eligible studies for this question.
1 finding from 1 review
Quality of life (1 to 6 months post intervention) · adult patients with harmful or hazardous alcohol or substance use
Primary health professional‐ and community professional‐led… showed no clear difference in quality of life (1 to 6 months post intervention) compared with enhanced usual care (moderate certainty).
1 finding from 1 review
Poor oral health-related quality of life (OHRQoL) · Children aged 3-12 years
Children from low-income families had higher odds of poor OHRQoL (OR 1.16, 95% CI 1.11-1.21; 4 studies; ungraded).
1 finding from 1 review
OR 1.16 [1.11, 1.21]
4 studies
GRADE not reported
Poor oral health-related quality of life (OHRQoL) · Children aged 3-12 years
Children aged 3 years had higher odds of poor OHRQoL than older children (OR 2.00, 95% CI 1.42-2.57; 2 studies; ungraded).
2 findings from 1 review
OR 2.00 [1.42, 2.57]
2 studies
GRADE not reported
OR 2.13 [1.50, 2.76]
2 studies
GRADE not reported
Poor oral health-related quality of life (OHRQoL) · Children aged 3-12 years
A trim-and-fill sensitivity analysis pooling every exposure estimate gave an overall OR of 0.17 (95% CI 0.13-0.21) after correcting for significant publication bias (Fig. 13); this combined estimate spans heterogeneous exposures and is a publication-bias sensitivity result (ungraded).
1 finding from 1 review
Poor oral health-related quality of life (OHRQoL) · Children aged 3-12 years
Periodontal disease was associated with higher odds of poor OHRQoL (OR 1.15, 95% CI 1.12-1.18; 3 studies; no heterogeneity; ungraded).
1 finding from 1 review
OR 1.15 [1.12, 1.18]
3 studies
GRADE not reported